Table 1. Characteristics of individuals included in the study.
Users group (n=224) | Non-users group (n=5821) | P-value | |
---|---|---|---|
Positive FIT | 21 (9.3%) | 365 (6.2%) | 0.07 |
Age (years-old) | 62.2 (s.d.: 5.6) | 59.4 (s.d.: 5.5) | <0.001 |
Male sex (%) | 140 (54.1%) | 2663 (46%) | 0.003 |
Proton pump inhibitor |
134 (60%) |
874 (15%) |
<0.001 |
Cardiac disease | |||
Valve prosthesis | 28 (12.5%) | — | |
Atrial fibrillation | 140 (62.5%) | 128 (2.2%) | <0.001 |
Prevention thromboembolism | 42 (18.75%) | — | |
Others |
14 (6.5%) |
— |
|
Ischemic stroke-heart |
67 (30%) |
320 (5.5%) |
<0.001 |
Results of colonoscopy | |||
Cancer | 1 (4.8%) | 19 (5.2%) | 0.5 |
Advanced adenoma | 9 (42.9%) | 165 (45.2%) | |
Non-advanced adenoma | 4 (19%) | 64 (17.5%) | |
Normal |
7 (33.3%) |
117 (32.1%) |
|
Location of lesions | |||
Distal | 10 (71.5%) | 180 (72.6%) | 0.5 |
Proximal | 4 (28.5%) | 68 (27.4%) |
Abbreviation: FIT=faecal immunochemical test.